These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2162749

  • 1. Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies.
    Stoschitzky K, Klein W, Stark G, Stark U, Zernig G, Graziadei I, Lindner W.
    Clin Pharmacol Ther; 1990 Jun; 47(6):740-6. PubMed ID: 2162749
    [Abstract] [Full Text] [Related]

  • 2. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
    Stoschitzky K, Egginger G, Zernig G, Klein W, Lindner W.
    Chirality; 1993 Jun; 5(1):15-9. PubMed ID: 8383518
    [Abstract] [Full Text] [Related]

  • 3. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
    Groschner K, Lindner W, Schnedl H, Kukovetz WR.
    Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
    [Abstract] [Full Text] [Related]

  • 4. Stereoselective electrophysiological effects of propafenone in Langendorff perfused guinea pig hearts.
    Stark U, Stark G, Stoschitzky K, Pilger E, Nagl S, Lindner W, Tritthart HA.
    Basic Res Cardiol; 1992 Mar; 87(1):87-97. PubMed ID: 1567355
    [Abstract] [Full Text] [Related]

  • 5. Stereoselective hemodynamic effects of (R)-and (S)-propranolol in man.
    Stoschitzky K, Lindner W, Rath M, Leitner C, Uray G, Zernig G, Moshammer T, Klein W.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):474-8. PubMed ID: 2739756
    [Abstract] [Full Text] [Related]

  • 6. Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.
    McLeod AA, Stiles GL, Shand DG.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):461-6. PubMed ID: 6141285
    [Abstract] [Full Text] [Related]

  • 7. An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy.
    Kroemer HK, Fromm MF, Bühl K, Terefe H, Blaschke G, Eichelbaum M.
    Circulation; 1994 May; 89(5):2396-400. PubMed ID: 7910120
    [Abstract] [Full Text] [Related]

  • 8. Propafenone shows class Ic and class II antiarrhythmic effects.
    Stoschitzky K, Stoschitzky G, Lercher P, Brussee H, Lamprecht G, Lindner W.
    Europace; 2016 Apr; 18(4):568-71. PubMed ID: 26056191
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization.
    Nanoff C, Schütz W.
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):837-42. PubMed ID: 1725895
    [Abstract] [Full Text] [Related]

  • 10. Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels.
    Stoschitzky K, Lindner W, Egginger G, Brunner F, Obermayer-Pietsch B, Passath A, Klein W.
    Clin Pharmacol Ther; 1992 Apr; 51(4):445-53. PubMed ID: 1563214
    [Abstract] [Full Text] [Related]

  • 11. Stereoselective disposition and pharmacologic activity of propafenone enantiomers.
    Kroemer HK, Funck-Brentano C, Silberstein DJ, Wood AJ, Eichelbaum M, Woosley RL, Roden DM.
    Circulation; 1989 May; 79(5):1068-76. PubMed ID: 2713973
    [Abstract] [Full Text] [Related]

  • 12. Stereoselective interactions of (R)- and (S)-propafenone with the cardiac sodium channel.
    Schreibmayer W, Lindner W.
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):324-31. PubMed ID: 1381026
    [Abstract] [Full Text] [Related]

  • 13. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
    Greenberg S, Cantor E, Paul J.
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
    [Abstract] [Full Text] [Related]

  • 14. The differentiation of propafenone from other class Ic agents, focusing on the effect on ventricular response rate attributable to its beta-blocking action.
    Faber TS, Camm AJ.
    Eur J Clin Pharmacol; 1996 Sep; 51(3-4):199-208. PubMed ID: 9010685
    [Abstract] [Full Text] [Related]

  • 15. The electrophysiologic effects of propafenone hydrochloride in the neonatal canine.
    Villafane J, Gelband H, Xu H, McCormack J, Stolfi A, Pickoff AS.
    Pediatr Res; 1987 Jul; 22(1):50-4. PubMed ID: 3627871
    [Abstract] [Full Text] [Related]

  • 16. Are there stereoselective electrophysiologic effects of intravenously administered (S)- or (R)-propafenone hydrochloride in patients with supraventricular tachycardia?
    Candinas R, Gloor HO, Lindner W, Ha HR, Buchinger W, Amann FW, Follath F.
    Eur J Clin Pharmacol; 1996 Jul; 50(3):185-90. PubMed ID: 8737757
    [Abstract] [Full Text] [Related]

  • 17. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
    Stoschitzky K, Lindner W.
    Wien Med Wochenschr; 1990 Apr 15; 140(6-7):156-62. PubMed ID: 1971978
    [Abstract] [Full Text] [Related]

  • 18. Lack of clinically significant beta-blocking effect of propafenone.
    Cheriex EC, Krijne R, Brugada P, Heymeriks J, Wellens HJ.
    Eur Heart J; 1987 Jan 15; 8(1):53-6. PubMed ID: 2880719
    [Abstract] [Full Text] [Related]

  • 19. Clinical pharmacokinetics of propafenone.
    Hii JT, Duff HJ, Burgess ED.
    Clin Pharmacokinet; 1991 Jul 15; 21(1):1-10. PubMed ID: 1914339
    [Abstract] [Full Text] [Related]

  • 20. Effect of propafenone hydrochloride on lymphocyte membrane beta 2 adrenoceptors in ventricular arrhythmias.
    Drici MD, Sbirrazzuoli V, Garraffo R, Wajman A, Morand P, Lapalus P.
    Am J Cardiol; 1989 Sep 15; 64(10):671-4. PubMed ID: 2476926
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.